{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:50:47Z","timestamp":1790369447582,"version":"4.1.0"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T00:00:00Z","timestamp":1600041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1003225","type":"journal-article","created":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T20:04:22Z","timestamp":1600113862000},"page":"e1003225","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Reassessment of the risk of narcolepsy in children in England 8 years after receipt of the AS03-adjuvanted H1N1 pandemic vaccine: A case-coverage study"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3999-6461","authenticated-orcid":true,"given":"Julia","family":"Stowe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Gringras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2397-3652","authenticated-orcid":true,"given":"Timothy","family":"Quinnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenobia","family":"Zaiwalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Shneerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1884-0097","authenticated-orcid":true,"given":"Elizabeth","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,9,14]]},"reference":[{"issue":"3","key":"pmed.1003225.ref001","doi-asserted-by":"crossref","first-page":"e33723","DOI":"10.1371\/journal.pone.0033723","article-title":"Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland","volume":"7","author":"M Partinen","year":"2012","journal-title":"PLoS ONE"},{"issue":"2","key":"pmed.1003225.ref002","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/joim.12150","article-title":"Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: a population- and registry-based cohort study with over 2 years of follow-up","volume":"275","author":"I Persson","year":"2014","journal-title":"J Intern Med"},{"issue":"3","key":"pmed.1003225.ref003","doi-asserted-by":"crossref","first-page":"e33536","DOI":"10.1371\/journal.pone.0033536","article-title":"AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland","volume":"7","author":"H Nohynek","year":"2012","journal-title":"PloS ONE"},{"key":"pmed.1003225.ref004","unstructured":"Department of Health I, Health Protection Agency. Pandemic H1N1 (Swine) Influenza Vaccine Uptake amongst Patient Groups in Primary Care in England 2009\/10 [Internet]. [cited 2020 Aug 25]. Available from: https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/215977\/dh_121014.pdf"},{"key":"pmed.1003225.ref005","doi-asserted-by":"crossref","first-page":"f794","DOI":"10.1136\/bmj.f794","article-title":"Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A\/H1N1 2009 influenza vaccine: retrospective analysis","volume":"346","author":"E Miller","year":"2013","journal-title":"BMJ"},{"issue":"5","key":"pmed.1003225.ref006","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.5665\/sleep.5752","article-title":"Risk of Narcolepsy after AS03 Adjuvanted Pandemic A\/H1N1 2009 Influenza Vaccine in Adults: A Case-Coverage Study in England","volume":"39","author":"J Stowe","year":"2016","journal-title":"Sleep"},{"key":"pmed.1003225.ref007","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.smrv.2017.06.006","article-title":"Incidence of narcolepsy after H1N1 influenza and vaccinations: Systematic review and meta-analysis","volume":"38","author":"TO Sarkanen","year":"2018","journal-title":"Sleep Med Rev"},{"issue":"Suppl 2","key":"pmed.1003225.ref008","doi-asserted-by":"crossref","first-page":"B6","DOI":"10.1016\/j.vaccine.2015.03.026","article-title":"The narcolepsy-pandemic influenza story: can the truth ever be unraveled?","volume":"33","author":"MC Sturkenboom","year":"2015","journal-title":"Vaccine"},{"issue":"1","key":"pmed.1003225.ref009","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/21645515.2015.1068486","article-title":"Pandemrix and narcolepsy: A critical appraisal of the observational studies","volume":"12","author":"T Verstraeten","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"pmed.1003225.ref010","unstructured":"Health and Social Care Information Centre. Hospital Episode Statistics 2016 [27\/07\/2016]. [cited 2020 Aug 25]. Available from: http:\/\/www.hscic.gov.uk\/hes"},{"key":"pmed.1003225.ref011","volume-title":"International classification of sleep disorders","author":"American Academy of Sleep Medicine","year":"2014","edition":"3"},{"issue":"15\u201316","key":"pmed.1003225.ref012","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1016\/j.vaccine.2004.01.017","article-title":"Control without separate controls: evaluation of vaccine safety using case-only methods","volume":"22","author":"CP Farrington","year":"2004","journal-title":"Vaccine"},{"key":"pmed.1003225.ref013","unstructured":"The Clinical Practice Research Datalink (CPRD) [Internet]. [cited 2020 Aug 25]. Available from: http:\/\/www.cprd.com"},{"key":"pmed.1003225.ref014","unstructured":"Office for National Statistics, Population Estimates Unit. Estimated resident population mid year [Internet]. [cited 2020 Aug 25]. Available from: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/populationandmigration\/populationestimates"},{"key":"pmed.1003225.ref015","article-title":"Do Vaccines Trigger Neurological Diseases? Epidemiological Evaluation of Vaccination and Neurological Diseases Using Examples of Multiple Sclerosis, Guillain-Barre Syndrome and Narcolepsy","author":"J Stowe","year":"2019","journal-title":"CNS Drugs"},{"issue":"8","key":"pmed.1003225.ref016","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/pds.4788","article-title":"Change in risk for narcolepsy over time and impact of definition of onset date following vaccination with AS03 adjuvanted pandemic A\/H1N1 influenza vaccine (Pandemrix) during the 2009 H1N1 influenza pandemic","volume":"28","author":"F Granath","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"pmed.1003225.ref017","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.sleep.2017.02.026","article-title":"Retrospective multicenter matched case-control study on the risk factors for narcolepsy with special focus on vaccinations (including pandemic influenza vaccination) and infections in Germany","volume":"34","author":"D Oberle","year":"2017","journal-title":"Sleep medicine"},{"key":"pmed.1003225.ref018","article-title":"Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines\u2013Multi-country assessment","author":"D Weibel","year":"2018","journal-title":"Vaccine"},{"issue":"9","key":"pmed.1003225.ref019","doi-asserted-by":"crossref","first-page":"e108489","DOI":"10.1371\/journal.pone.0108489","article-title":"Risk of narcolepsy associated with inactivated adjuvanted (AS03) A\/H1N1 (2009) pandemic influenza vaccine in Quebec","volume":"9","author":"J Montplaisir","year":"2014","journal-title":"PloS ONE"},{"issue":"7","key":"pmed.1003225.ref020","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11910-018-0851-5","article-title":"Narcolepsy Associated with Pandemrix Vaccine","volume":"18","author":"T Sarkanen","year":"2018","journal-title":"Curr Neurol Neurosci Rep"},{"key":"pmed.1003225.ref021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biologicals.2019.05.005","article-title":"Meeting report narcolepsy and pandemic influenza vaccination: What we know and what we need to know before the next pandemic? A report from the 2nd IABS meeting","volume":"60","author":"K Edwards","year":"2019","journal-title":"Biologicals"},{"issue":"3","key":"pmed.1003225.ref022","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/ana.22587","article-title":"Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China","volume":"70","author":"F Han","year":"2011","journal-title":"Annals of neurology"},{"key":"pmed.1003225.ref023","article-title":"Narcolepsy and 2009 H1N1 pandemic vaccination in Taiwan","author":"WT Huang","year":"2018","journal-title":"Sleep Medicine"},{"issue":"8","key":"pmed.1003225.ref024","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/INF.0000000000002398","article-title":"Narcolepsy and Pandemic Influenza Vaccination: What We Need to Know to be Ready for the Next Pandemic.","volume":"38","author":"K Edwards","year":"2019","journal-title":"Pediatr Infect Dis J"},{"issue":"16","key":"pmed.1003225.ref025","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/j.vaccine.2017.02.059","article-title":"Effectiveness of 2009 pandemic influenza A(H1N1) vaccines: A systematic review and meta-analysis","volume":"35","author":"LE Lansbury","year":"2017","journal-title":"Vaccine"},{"key":"pmed.1003225.ref026","unstructured":"US Food & Drug Administration. Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted, manufactured by ID Biomedical Corporation\u2013Questions and Answers [06\/11\/2019]. [cited 2020 Aug 25]. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/safety-availability-biologics\/influenza-h5n1-virus-monovalent-vaccine-adjuvanted-manufactured-id-biomedical-corporation-questions"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003225","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T20:04:49Z","timestamp":1600113889000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003225"}},"subtitle":[],"editor":[{"given":"Jonathan","family":"Duffy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,9,14]]},"references-count":26,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1003225","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,14]]}}}